Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Jan 1, 2026
Reporting period
Not applicable
Filed with the SEC
Jan 5, 2026
DirectorGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001809519-26-000003
Filed / recorded
Jan 5, 2026, 10:18 PM UTC
Added to OQRO
Oct 7, 2026, 5:51 AM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
GoodRx Holdings, Inc.
Issuer CIK
1809519
Ticker
GDRX
Reporting person
Ronald E Bruehlman
Relationship
Director
Security
Class A Common Stock
Table
Non-derivative (Table I)
Transaction date
Jan 1, 2026
Transaction code
A
Shares / units
18,251
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
129,276
Ownership form
Direct
Amendment
No
Footnotes from the filing
Reflects deferred stock units. Each deferred stock unit represents a contingent right to receive one share of Class A common stock. The deferred stock units will vest in substantially equal monthly installments beginning on January 31, 2026 and ending on December 31, 2026, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2031; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors).
